Clinical Trial Update: Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia (CCCA) [Phase 4]

View source ↗

Summary

Phase 4 trial update for apremilast in central centrifugal cicatricial alopecia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Centrifugal Cicatricial Alopecia

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Central Centrifugal Cicatricial Alopecia | Phase 4 | Status: COMPLETED | Results posted: 2022-05-09